Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
EKR Therapeutics
company
About
EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $13M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Feb 1, 2006
- Number Of Employee
- 51 - 100
- Operating Status
- Active
EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$68M
EKR Therapeutics has raised a total of
$68M
in funding over 2 rounds. Their latest funding was raised on
Mar 10, 2008 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 10, 2008 | Series D | $50M | 2 | — | — | Detail |
| Aug 15, 2007 | Series C | $13M | 2 | — | — | Detail |
| Jul 3, 2006 | Series B | $5M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
EKR Therapeutics is funded by 3 investors.
Garden State Life Sciences Venture
and ESP Equity Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
